AUG 01, 2019 09:59 PM PDT

A Safer Cannabis Extract Could Help Users Fight Cannabis Dependence

WRITTEN BY: C Reardon

According to The National Institute on Drug Abuse, roughly 30% of recreational cannabis users in the U.S. may be at risk of having some degree of cannabis use disorder resulting in symptoms of dependence. Dependence often manifests in irritability, changes in appetite, and poor sleep patterns. The UN Office on Drugs and Crime says that cannabis is the most widely used psychoactive substance used and accounts for the largest number of people dependent on illicit drugs globally.

In a study on the likelihood of developing an alcohol and cannabis use disorder during youth, it was found that those who begin using marijuana regularly before the age of 18 are four to seven times more likely to develop a marijuana use disorder than adult users. 

Marijuana use disorder turns into addiction when a user cannot stop using the drug even though it interferes with daily life. Estimating the number of people addicted to marijuana can be controversial, mainly because epidemiological studies of substance use often use dependence as a substitute for addiction. However, it is possible to be dependent without being addicted.

In a recent study, researchers from the University of Sydney and the New South Wales Ministry of Health in Australia tested a new medicinal drug called Nabiximols for the treatment of cannabis dependence. This was a randomized clinical trial consisting of 128 participants who were all recreational cannabis users. The participants were monitored over 12 weeks, and only some of them were given the actual drug, administered in spray form, orally, under the tongue. The researchers gave each participant an average dose of 18 sprays per day; each spray was 0.1 milliliters, containing 2.7 milligrams (mg) of THC and 2.5 mg of CBD.

Photo Source: MEL Magazine 

The research found that Nabiximols, a cannabinoid agonist drug, made up of a combination of cannabidiol (CBD) and tetrahydrocannabinol (THC), resulted in fewer days of illicit cannabis use in patients who received the drug compared to those who received a placebo. 

This cannabinoid agonist, consisting of a cannabis extract, works through interaction with the body's cannabinoid receptors. Cannabinoid receptors are part of the endocannabinoid system, which is involved in a variety of physiological processes including appetite, pain-sensation, mood, and memory. Through targeting these receptors researchers hope to reduce the rate of relapse in those seeking help for cannabis dependence. 

"The principles are very similar to nicotine replacement; you are providing patients with a medicine, which is safer than the drug they're already using and linking this with medical and counseling support to help people address their illicit cannabis use," Prof. Lintzeris, lead author on the study, explains.

Currently, four out of five patients relapse to regular cannabis use within six months of medical or psychological interventions.

 

About the Author
You May Also Like
JAN 19, 2020
Immunology
JAN 19, 2020
Increased Belly Fat with Aging Linked to Reduced Mental Flexibility
Did you ever consider that your brain can flex similarly to the way your biceps can? Sure, brain flexing is more abstract and less literal, but the concept...
JAN 19, 2020
Cell & Molecular Biology
JAN 19, 2020
Learning More About How Mosquitoes Gain Resistance to Insecticides
When insecticides are used repeatedly over time to kill mosquitoes, they become less effective as the insects gain resistance to their impacts....
JAN 19, 2020
Clinical & Molecular DX
JAN 19, 2020
Kiss and tell: new test for kissing bug disease
Here’s one Latin lover that you do not want to get kissed by: triatomines, or “kissing bugs”. Known locally as pitos or chipos, these ins...
JAN 19, 2020
Cardiology
JAN 19, 2020
Healthy Sleep May Offset Genetic Heart Disease Risk
People with a high genetic risk of heart disease or stroke may be able to offset that risk with healthy sleep patterns, according to new research. The rese...
JAN 19, 2020
Cannabis Sciences
JAN 19, 2020
Virginia Governor Pushes Cannabis Decriminalization
Will the Old Dominion accept marijuana decriminalization? Democrats took the majority in Virginia’s state House and Senate in 2019, opening the door ...
JAN 19, 2020
Genetics & Genomics
JAN 19, 2020
Genetic Study Reveals Drug Targets for Several Diseases
Some genetic mutations are due to a change in only one base of the genetic code, while others involve large regions of the genome....
Loading Comments...